1
|
APP
|
BC065529
|
amyloid beta (A4) precursor protein
|
literature, [2], Down regulation in DS, [65]
|
2
|
CAST
|
NM_015576
|
CAZ-associated structural protein
|
literature, [40]
|
3
|
CD59
|
BC001506
|
CD59 antigen p18-20
|
literature, [66]
|
4
|
CDC10
|
BX648365
|
cell division cycle 10
|
literature, [67]
|
5
|
HK1
|
NM_033500
|
hexokinase 1
|
literature, [68]
|
6
|
PFKP
|
BC002536
|
phosphofructokinase
|
literature, [37]
|
7
|
PTPN11
|
NM_002834
|
protein tyrosine phosphatase, non-receptor type 11
|
literature, [69]
|
8
|
RPIP8
|
BC013240
|
RaP2interacting protein 8
|
literature, [3]
|
9
|
SCD
|
NM_005063
|
stearoyl-CoA desaturase
|
literature, [70]
|
10
|
SERPINE2
|
NM_006216
|
serine (or cysteine) proteinase inhibitor, clade E, member 2
|
literature, [41]
|
11
|
UCHL1
|
BC000332
|
ubiquitin thiolesterase, UCHL1
|
literature [71,72].
|
12
|
SNCA
|
NM_000345
|
synuclein, alpha
|
qRT-PCR, literature, [2]
|
13
|
A2M
|
BC040071
|
alpha-2-macroglobulin
|
mutation of A2M is linked to AD, [16]
|
14
|
BRI3
|
BC018737
|
Brain protein I3
|
mutation of BRI2 is liked to neurodegeneration[19]
|
15
|
EEF1A1
|
BC009875
|
Eukaryotic translation elongation factor 1 alpha 1
|
mutation, mutant mice exhibit neurodegeneration, [14]
|
16
|
EIF2S2
|
BC000461
|
Eukaryotic translation initiation factor 2, subunit 2 beta
|
mutation, mutations causing childhood ataxia, [15]
|
17
|
MAPT
|
BC032572
|
microtubule-associated protein tau, long splice form
|
mutation, mutation in exon 9–13 cause neurodegenerative diseases including AD, [18]
|
18
|
UBB
|
BC038999
|
ubiquitin B
|
mutation, frame shift mutation fund in AD, [17]
|
19
|
ATP2B1
|
AK024895
|
ATPase, Ca++ transporting, plasma membrane 1
|
inferred, expression is repressed by stress, [21]
|
20
|
CDK5R1
|
BC035448
|
cyclin-dependent kinase 5, regulatory subunit 1
|
inferred, [73], and in ethanol induced neurodegeneration, [23]
|
21
|
CPLX1
|
BC002471
|
complexin 1
|
inferred, Down regulated in schizophrenia, [24]
|
22
|
NES
|
AF086454
|
nestin
|
inferred, decreased in injured aged hippocampus, [20]
|
23
|
RAD21
|
NM_006265
|
RAD21 homolog
|
inferred, Down regulated by hypoxia, [26]
|
24
|
ST13
|
BC052982
|
suppression of tumorigenicity 13
|
inferred, rescue phosphorylated tau-induced cell death [25]
|
25
|
TAGLN3
|
AF303058
|
transgelin 3
|
inferred, down regulated in schizophrenia, [22]
|
26
|
ARF6
|
BC030291
|
ADP-ribosylation factor 6
|
qRT-PCR
|
27
|
BCAS1
|
NM_003657
|
Breast carcinoma amplified sequence 1
|
qRT-PCR
|
28
|
CKIP-1
|
BC010149
|
CK2 interacting protein 1
|
qRT-PCR
|
29
|
CRI1
|
AL357456
|
CREBP/EP300 inhibitory protein 1
|
qRT-PCR
|
30
|
DEAF1
|
BC053322
|
deformed epidermal autoregulatory factor 1
|
qRT-PCR
|
31
|
SCA1
|
NM_000332
|
spinocerebellar ataxia 1
|
qRT-PCR
|
32
|
SV2A
|
BC045111
|
synaptic vesicle glycoprotein 2A
|
qRT-PCR
|
33
|
TPI1
|
BC017917
|
triosephosphate isomerase
|
qRT-PCR
|
34
|
UBE2B
|
NM_003337
|
ubiquitin-conjugating enzyme E2B
|
qRT-PCR
|
35
|
RELN
|
NM_005045
|
reelin
|
qRT-PCR and inferred, down regulation or mutation cause autistic disorder, [27]
|
36
|
PRKCE
|
BC054052
|
protein kinase C, epsilonY
|
qRT-PCR and inferred, suppresses Aβ production, [28]
|
37
|
SYT4
|
BC036538
|
synaptotagmin IV
|
qRT-PCR, inferred, SYT(unspecified isoform) is down regulated in CA1 of AD brains, [2]
|